Journal of Multidisciplinary Applied Natural Science
##plugins.themes.gdThemes.journalSlogan##
Scopus CiteScore 2024
4.8
Calculated on 05 May, 2025
SJR 2024
0.31
Powered by scimagojr.com
##plugins.themes.gdThemes.journalSlogan##
4.8
Calculated on 05 May, 2025
0.31
Powered by scimagojr.com
https://doi.org/10.47352/jmans.2774-3047.259
Maria Ludya Pulung
Respati Tri Swasono
Eti Nurwening Sholikhah
Radite Yogaswara
Gian Primahana
Tri Joko Raharjo
Hyrtios sponge is known to possess alkaloid compounds that may exhibit in vitro activity against Plasmodium falciparum. The aim of this study was therefore to isolate and characterise the antiplasmodial active compounds of Hyrtios sp. Sponges collected from the island of Podang-Podang, South Sulawesi, Indonesia. In addition, the LC-HRMS analysis was performed on the active fractions of methanol and ethyl acetate extract to evaluate their antiplasmodial activity. We also validated the in silico antiplasmodial activity of PfDHFR-TS with molecular docking, pharmacokinetics, drug likeness, toxicity, and molecular dynamics analysis. The molecular docking studies showed that the synthesized extremes would have high binding affinity to PfDHFR-TS, thus confirming their potential as powerful enzyme inhibitors. Moreover, the pharmacokinetic and drug-likeness calculations showed that all compounds met the requirements for sufficient resistance and bioavailability, indicating potential as therapeutic candidates. The results of the toxicity analysis indicated that the compounds had a relatively good safety profile, but some potential adverse reactions in the renal and cardiac vasculature could not be excluded. Molecular dynamics simulations confirmed that the complexes formed between the ligand and the target were stable, and the low RMSD value indicated that the active site interactions were also quite stable. These observations reinforce the notion that the extract from Hyrtios sp. not only shows remarkable antimalarial activity but also exhibits pharmacological properties of a prospective drug candidate, which encourages further work in the development of malaria combination therapy both in clinical assessment and comprehensive mechanism of action investigation.
[1] M. Mushtaque and Shahjahan. (2015). "Reemergence of chloroquine (CQ) analogs as multi-targeting antimalarial agents: a review". European Journal of Medicinal Chemistry. 90 : 280-95. 10.1016/j.ejmech.2014.11.022.
DOI: https://doi.org/10.1016/j.ejmech.2014.11.022[2] A. Monroe, N. A. Williams, S. Ogoma, C. Karema, and F. Okumu. (2022). "Reflections on the 2021 World Malaria Report and the future of malaria control". Malaria Journal. 21 (1): 154. 10.1186/s12936-022-04178-7.
DOI: https://doi.org/10.1186/s12936-022-04178-7[3] I. Fadilah, B. A. Djaafara, K. D. Lestari, S. B. Fajariyani, E. Sunandar, B. G. Makamur, B. Wopari, S. Mabui, L. L. Ekawati, R. Sagara, R. N. Lina, G. Argana, D. E. Ginting, M. E. Sumiwi, F. J. Laihad, I. Mueller, J. McVernon, J. K. Baird, H. Surendra, and I. R. F. Elyazar. (2022). "Quantifying spatial heterogeneity of malaria in the endemic Papua region of Indonesia: Analysis of epidemiological surveillance data". The Lancet Regional Health – Southeast Asia. 5 : 100051. 10.1016/j.lansea.2022.100051.
DOI: https://doi.org/10.1016/j.lansea.2022.100051[4] J. C. Craft. (2008). "Challenges facing drug development for malaria". Current Opinion in Microbiology. 11 (5): 428-33. 10.1016/j.mib.2008.09.003.
DOI: https://doi.org/10.1016/j.mib.2008.09.003[5] A. C. C. Aguiar, J. R. Parisi, R. N. Granito, L. R. F. de Sousa, A. C. M. Renno, and M. L. Gazarini. (2021). "Metabolites from Marine Sponges and Their Potential to Treat Malarial Protozoan Parasites Infection: A Systematic Review". Marine Drugs. 19 (3). 10.3390/md19030134.
DOI: https://doi.org/10.3390/md19030134[6] N. H. Shady, E. M. El-Hossary, M. A. Fouad, T. A. M. Gulder, M. S. Kamel, and U. R. Abdelmohsen. (2017). "Bioactive Natural Products of Marine Sponges from the Genus Hyrtios". Molecules. 22 (5). 10.3390/molecules22050781.
DOI: https://doi.org/10.3390/molecules22050781[7] G. Kirsch, G. M. Kong, A. D. Wright, and R. Kaminsky. (2000). "A new bioactive sesterterpene and antiplasmodial alkaloids from the marine sponge hyrtios cf. erecta". Journal of Natural Products. 63 (6): 825-9. 10.1021/np990555b.
DOI: https://doi.org/10.1021/np990555b[8] M. Mahfur, I. Purwantini, S. Wahyuono, and E. P. Setyowati. (2022). "In vitro antiplasmodial activities of the fractions of Hyrtios reticulatus sponge extract". Journal of Applied Pharmaceutical Science. 10.7324/japs.2022.120913.
DOI: https://doi.org/10.7324/JAPS.2022.120913[9] E. Ju, A. Latif, C. S. Kong, Y. Seo, Y. J. Lee, S. R. Dalal, M. B. Cassera, and D. G. I. Kingston. (2018). "Antimalarial activity of the isolates from the marine sponge Hyrtios erectus against the chloroquine-resistant Dd2 strain of Plasmodium falciparum". Zeitschrift für Naturforschung C : Journal of Biosciences. 73 (9-10): 397-400. 10.1515/znc-2018-0025.
DOI: https://doi.org/10.1515/znc-2018-0025[10] M. Salmoun, C. Devijver, D. Daloze, J. C. Braekman, and R. W. van Soest. (2002). "5-hydroxytryptamine-derived alkaloids from two marine sponges of the genus Hyrtios". Journal of Natural Products. 65 (8): 1173-6. 10.1021/np020009+.
DOI: https://doi.org/10.1021/np020009+[11] D. T. Youssef. (2005). "Hyrtioerectines A-C, cytotoxic alkaloids from the red sea sponge hyrtioserectus". Journal of Natural Products. 68 (9): 1416-9. 10.1021/np050142c.
DOI: https://doi.org/10.1021/np050142c[12] M. S. Valdes-Tresanco, M. E. Valdes-Tresanco, P. A. Valiente, and E. Moreno. (2020). "AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4". Biology Direct. 15 (1): 12. 10.1186/s13062-020-00267-2.
DOI: https://doi.org/10.1186/s13062-020-00267-2[13] W. Trager and J. B. Jensen. (2005). "Human Malaria Parasites in Continuous Culture". Journal of Parasitology. 91 (3): 484-486. 10.1645/0022-3395(2005)091[0484:Hmpicc]2.0.Co;2.
[14] O. Taglialatela-Scafati, E. Fattorusso, A. Romano, F. Scala, V. Barone, P. Cimino, E. Stendardo, B. Catalanotti, M. Persico, and C. Fattorusso. (2010). "Insight into the mechanism of action of plakortins, simple 1,2-dioxane antimalarials". Organic & Biomolecular Chemistry. 8 (4): 846-56. 10.1039/b918600j.
DOI: https://doi.org/10.1039/B918600J[15] G. F. Swandiny, G. Primahana, M. E. Prastya, N. Ariani, D. Susanti, M. Hanafi, and S. Abdillah. (2023). "An ethnopharmacology study of Indonesian medicinal plants in Gunung Sari village as dipeptidyl peptidase-IV inhibitor". Pharmacia. 70 (2): 365-373. 10.3897/pharmacia.70.e104437.
DOI: https://doi.org/10.3897/pharmacia.70.e104437.figure1[16] R. Yogaswara, M. L. Pulung, S. H. Yuliani, and E. P. Istyastono. (2020). "Docking-Guided 3D-QSAR Studies of 4-Aminoquinoline-1,3,5-triazines as Inhibitors for <i>Plasmodium falciparum</i> Dihydrofolate Reductase". Indonesian Journal of Chemistry. 20 (6). 10.22146/ijc.50674.
DOI: https://doi.org/10.22146/ijc.50674[17] G. Nugraha and E. P. Istyastono. (2021). "Virtual Target Construction for Structure-Based Screening in the Discovery of Histamine H2 Receptor Ligands". International Journal of Applied Pharmaceutics. 239-241. 10.22159/ijap.2021v13i3.41202.
DOI: https://doi.org/10.22159/ijap.2021v13i3.41202[18] E. M. Terefe and A. Ghosh. (2022). "Molecular Docking, Validation, Dynamics Simulations, and Pharmacokinetic Prediction of Phytochemicals Isolated From Croton dichogamus Against the HIV-1 Reverse Transcriptase". Bioinformatics and Biology Insights. 16 : 11779322221125605. 10.1177/11779322221125605.
DOI: https://doi.org/10.1177/11779322221125605[19] F. Azimi, H. Azizian, M. Najafi, F. Hassanzadeh, H. Sadeghi-Aliabadi, J. B. Ghasemi, M. Ali Faramarzi, S. Mojtabavi, B. Larijani, L. Saghaei, and M. Mahdavi. (2021). "Design and synthesis of novel quinazolinone-pyrazole derivatives as potential alpha-glucosidase inhibitors: Structure-activity relationship, molecular modeling and kinetic study". Bioorganic Chemistry. 114 : 105127. 10.1016/j.bioorg.2021.105127.
DOI: https://doi.org/10.1016/j.bioorg.2021.105127[20] N. D. Zaharuddin, I. Barkia, W. Z. Wan Ibadullah, M. Zarei, and N. Saari. (2022). "Identification, molecular docking, and kinetic studies of six novel angiotensin-I-converting enzyme (ACE) inhibitory peptides derived from Kenaf (Hibiscus cannabinus L.) seed". International Journal of Biological Macromolecules. 220 : 1512-1522. 10.1016/j.ijbiomac.2022.09.142.
DOI: https://doi.org/10.1016/j.ijbiomac.2022.09.142[21] A. Daina, O. Michielin, and V. Zoete. (2017). "SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules". Scientific Reports. 7 : 42717. 10.1038/srep42717.
DOI: https://doi.org/10.1038/srep42717[22] B. Bakchi, A. D. Krishna, E. Sreecharan, V. B. J. Ganesh, M. Niharika, S. Maharshi, S. B. Puttagunta, D. K. Sigalapalli, R. R. Bhandare, and A. B. Shaik. (2022). "An overview on applications of SwissADME web tool in the design and development of anticancer, antitubercular and antimicrobial agents: A medicinal chemist's perspective". Journal of Molecular Structure. 1259. 10.1016/j.molstruc.2022.132712.
DOI: https://doi.org/10.1016/j.molstruc.2022.132712[23] P. H. Riyadi, Romadhon, I. D. Sari, R. A. Kurniasih, T. W. Agustini, F. Swastawati, V. E. Herawati, and W. A. Tanod. (2021). "SwissADME predictions of pharmacokinetics and drug-likeness properties of small molecules present in Spirulina platensis". IOP Conference Series: Earth and Environmental Science. 890 (1). 10.1088/1755-1315/890/1/012021.
DOI: https://doi.org/10.1088/1755-1315/890/1/012021[24] P. Banerjee, E. Kemmler, M. Dunkel, and R. Preissner. (2024). "ProTox 3.0: a webserver for the prediction of toxicity of chemicals". Nucleic Acids Research. 52 (W1): W513-W520. 10.1093/nar/gkae303.
DOI: https://doi.org/10.1093/nar/gkae303[25] P. Banerjee, A. O. Eckert, A. K. Schrey, and R. Preissner. (2018). "ProTox-II: a webserver for the prediction of toxicity of chemicals". Nucleic Acids Research. 46 (W1): W257-W263. 10.1093/nar/gky318.
DOI: https://doi.org/10.1093/nar/gky318[26] E. Krieger and G. Vriend. (2015). "New ways to boost molecular dynamics simulations". Journal of Computational Chemistry. 36 (13): 996-1007. 10.1002/jcc.23899.
DOI: https://doi.org/10.1002/jcc.23899[27] K. Imada, E. Sakai, H. Kato, T. Kawabata, S. Yoshinaga, T. Nehira, H. Terasawa, and S. Tsukamoto. (2013). "Reticulatins A and B and hyrtioreticulin F from the marine sponge Hyrtios reticulatus". Tetrahedron. 69 (34): 7051-7055. 10.1016/j.tet.2013.06.043.
DOI: https://doi.org/10.1016/j.tet.2013.06.043[28] J. Yuvaniyama, P. Chitnumsub, S. Kamchonwongpaisan, J. Vanichtanankul, W. Sirawaraporn, P. Taylor, M. D. Walkinshaw, and Y. Yuthavong. (2003). "Insights into antifolate resistance from malarial DHFR-TS structures". Nature Structural & Molecular Biology. 10 (5): 357-65. 10.1038/nsb921.
DOI: https://doi.org/10.1038/nsb921[29] R. Ferreira de Freitas and M. Schapira. (2017). "A systematic analysis of atomic protein-ligand interactions in the PDB". MedChemComm. 8 (10): 1970-1981. 10.1039/c7md00381a.
DOI: https://doi.org/10.1039/C7MD00381A